The relevance of cytokines in the radiation-induced lung reaction. Experimental basis and clinical significance;Die bedeutung von zytokinen für die radiogene lungenreaktion: Experimentelle grundlagen und klinische relevanz

Strahlentherapie und Onkologie

Volumn 180, Issue 9, 2004, Pages 541-549

  Rübe, Claudia E ^a   Rodemann, H Peter ^b   Rübe, Christian ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Cytokines; Pneumonitis; Radiation induced lung reaction; Radiotherapy

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; RADIOPROTECTIVE AGENT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BEAM THERAPY; CELL PROLIFERATION; CIRCULATION; CYTOKINE PRODUCTION; DISEASE COURSE; FIBROBLAST; GENE THERAPY; HOST; HUMAN; IMMUNOHISTOCHEMISTRY; IRRADIATION; LUNG FIBROSIS; LUNG INJURY; LUNG PARENCHYMA; NONHUMAN; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RADIATION DOSE; RADIATION INJURY; RADIATION PNEUMONIA; RADIOSENSITIVITY; REVIEW; THORAX TUMOR; TISSUE INJURY; TUMOR CELL;

ANIMALS; CLINICAL TRIALS; CYTOKINES; EVIDENCE-BASED MEDICINE; GENE THERAPY; HUMANS; LUNG; LUNG DISEASES; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS; THORACIC NEOPLASMS;

EID: 4544289917     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1279-1     Document Type: Review

References (71)

1. Anscher MS, Kong FM, Jirtle RL. The relevance of transforming growth factor β1 in pulmonary injury after radiation therapy. Lung Cancer 1998;19: 109-20.
2. Anscher MS, Kong FM, Marks LB, et al. Changes in plasma transforming growth factor β during radiotherapy and the risk of symptomatic radiation induced pneumonitis. Int J Radiat Oncol Biol Phys 1997;37:253-8.
3. Anscher MS, Marks LB, Shafman TD, et al. Using plasma transforming growth factor beta 1 during radiotherapy to select patients for dose escalation. J Clin Oncol 2001;19:3758-65.
4. Anscher MS, Murase T, Prescott DM, et al. Changes in plasma TGF-β levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys 1994;30:671-6.
5. Anscher MS, Peters WP, Reisenbichler H, et al. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 1993;328:1592-8.
6. Asselin Paturel C, Echchakir H, Carayol G, et al. Quantitative analysis of Th1, Th2 and TGF β1 cytokine expression in tumor, TIL and PBL of non small cell lung cancer patients. Int J Cancer 1998;77:7-12.
7. Bansal AS, Bruce J, Devine PI, et al. Serum cytokines and tumour markers in patients with non small cell carcinoma of the lung. Dis Markers 1997;13:195-7.
8. Barcellos Hoff MH, Derynck R, Tsang ML, et al. Transforming growth factor beta activation in irradiated murine mammary gland. J Clin Invest 1994;93:892-9.
9. Barcellos Hoff MH, Ehrhart EJ, Kalia M, et al. Immunohistochemical detection of active transforming growth factor beta in situ using engineered tissue. Am J Pathol 1995;147:1228-37.
10. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor β in human disease. N Engl J Med 2000;342:1350-7.
11. Burger A, Loffler H, Bamberg M, et al. Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol 1998;73:401-8.
12. Chen Y, Rubin P, Williams J, et al. Circulating IL 6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2001;49:641-8.
13. Clouthier DE, Comerford SA, Hammer RE. Hepatic fibrosis, glomerulosclerosis and a lipodystrophy like syndrome in PEPCK TGF β1 transgenic mice. J Clin Invest 1997;100:2697-713.
14. Dileto CL, Travis EL. Fibroblast radiosensitivity in vitro and lung fibrosis in vivo: comparison between a fibrosis prone and fibrosis resistant mouse strain. Radiat Res 1996;146:61-7.
15. Epperly MW, Bray JA, Kraeger S, et al. Prevention of late effects of irradiation lung damage by MnSOD gene therapy. Gene Ther 1998;5:196.
16. Epperly MW, Bray JA, Kraeger S, et al. Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation induced organizing alveolitis. Int J Radiat Oncol Biol Phys 1999;43:171.
17. Epperly MW, Travis EI, Sikora C, et al. Magnesium superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation induced mRNA for Il-1, TNF-β and TGF-β correlates with delay of organizing alveolitis/fibrosis. Biol Blood Marrow Transplant 1999;5:204-14.
18. Erhard EJ, Segarini P, Tsang ML, et al. Latent transforming growth factor β 1 activation in quantitative and functional evidence after low dose γ irradiation. FASEB J 1997;11:991-1002.
19. Finkelstein JN, Johnston CJ, Baggs R, et al. Early alterations in extracellular matrix and transforming growth factor β gene expression in mouse lung indicative of late radiation fibrosis. Int J Rad Oncol Biol Phys 1994;28: 621-31.
20. Franko AJ, Sharplin J. Development of fibrosis after lung irradiation in relation to inflammation and lung function in a mouse strain prone to fibrosis. Radiat Res 1994;140:347-55.
21. Franko AJ, Sharplin J, Ghahary A, et al. Immunohistochemical localization of transforming growth factor β and tumor necrosis factor α in the lungs of fibrosis prone and "non fibrosing" mice during the latent period and early phase after irradiation. Radiat Res 1997;147:245-6.
22. Franko AJ, Sharplin J, Ward WF, et al. The genetic basis of strain dependent differences in the early phase of radiation injury in mouse lung. Radiat Res 1991;126:349-56.
23. Franko AJ, Sharplin J, Ward WF, et al. Evidence for two patterns of inheritance of sensitivity to induction of lung fibrosis in mice by radiation, one of which involves two genes. Radiat Res 1996;146:68-74.
24. Fu XL, Huang H, Bentel G, et al. Predicting the risk of symptomatic radiation induced lung injury using both the physical and biologic parameters V30 and transforming growth factor β. Int J Radiat Oncol Biol Phys 2001;50:899-908.
25. Haase O, Rodemann HP. Activation of TGF-β1 und Smad2 in human skin fibroblasts following irradiation in vitro. Mol Radiat Biol Oncol 2003;4:67.
26. Hakenjos L, Bamberg M, Rodemann HP. TGF-β1 mediated alterations of rat lung fibroblast differentiation resulting in the radiation induced fibrotic response. Int J Radiat Biol 2000;76:503-9.
27. Hallahan DE, Spriggs, DR, Beckett MA, et al. Increased tumor necrosis factor α mRNA after cellular exposure to ionising radiation. Proc Natl Acad Sci USA 1989;86:10104-7.
28. Herrmann T, Knorr A. Die radiogene Lungenreaktion. Strahlenther Onkol 1995;171:490-8.
29. Hong JH, Chiang CS, Tsao CY, et al. Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation. Int J Radiat Biol 1999;75:1421-7.
30. Johnston CJ, Piedboeuf B, Baggs R, et al. Differences in correlation of mRNA gene expression in mice sensitive and resistant to radiation induced pulmonary fibrosis. Radiat Res 1995;142:197-203.
31. Johnston CJ, Piedboeuf B, Rubin P, et al. Early and persistent alterations in the expression of interleukin-α, interleukin-1β and tumor necrosis factor α mRNA levels in fibrosis resistant and sensitive mice after thoracic irradiation. Radiat Res 1996;145:762-7.
32. 1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg 1995;222:155-62.
33. 1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma. Cancer 1999;86:1712-9.p
34. Kong F, Washington MK, Jirtle RL, et al. Plasma transforming growth factor-β1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker. Lung Cancer 1996;16:47-59.
35. LENT SOMA Scales for all anatomic sites. Int J Radiat Oncol Biol Phys 1995;31:1049-91.
36. Martin M, Lefaix JL, Delanian S. TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target. Int J Radiat Oncol Biol Phys 2000; 47:277-90.
37. Massague J, Chen YG. Controlling TGF-β signalling. Genes Dev 2000;14: 627-44.
38. McDonald S, Rubin P, Phillips TL, et al. Injury of the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 1995;31:1187-203.
39. Molls M, van Beuningen D. Radiation injury of the lung: experimental studies, observations after radiotherapy and total body irradiation prior to bone marrow transplantation. In: Scherer E, Streffer C, Trott KR, eds. Radiopathology of organs and tissues. Berlin: Springer, 1991:369-404.
40. Morgan W, Seaton A. Occupational lung diseases. Philadelphia: Saunders, 1994.
41. Nieder C, Price RE, Rivera B, et al. Experimentelle Daten zum Einsatz von Insulin Like Growth Factor-1 (IGF-1) und Basic Fibroblast Growth Factor (bFGF) zur Prävention einer Strahlenmyelopathie. Strahlenther Onkol 2003; 178:147-52.
42. Norgaard P, Damstrup L, Rygaard K, et al. Acquired TGF-β1 sensitivity and TGF-β1 expression in cell lines established from a single small cell lung cancer patient during clinical progression. Lung Cancer 1996;14:63-73.
43. Pfeil A von, Hakenjos L, Herskind C, et al. Irradiated homozygous TGF-β1 knockout fibroblasts show enhanced clonogenic survival as compared with TGF-β1 wild type fibroblasts. Int J Radiat Biol 2002;78:331-9.
44. Piroth MD, Zierhut D, van Kampen M, et al. Lungendosis in Abhängigkeit von der Lagerungsgenauigkeit bei Ganzkörperbestrahlungen (TBI). Isoeffektivitätsüberlegungen zur Einschätzung des Risikos einer interstitiellen Pneumonitis nach Ganzkörperbestrahlung. Strahlenther Onkol 2003;178:43-9.
45. Roberts AB, Sporn MB. The transforming growth factor-βs. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors, vol 1. Berlin: Springer, 1990:419-72.
46. Rodemann HP, Bamberg M. Cellular basis of radiation induced fibrosis. Radiother Oncol 1995;35:83-90.
47. Rodemann HP, Binder A, Burger A. The underlying cellular mechanism of fibrosis. Kidney Int Suppl 1996;54:S32-6.
48. Rodemann HP, Peterson H P, Schwenke K, et al. Terminal differentiation of human fibroblasts is induced by radiation. Scanning Microsc 1992;5:1135-43.
49. Rübe C, Finke C, van Valen F, et al. Nachweis einer strahleninduzierten Produktion von Tumor-Nekrose-Faktor alpha im Ewing Sarkom RM 82 in vitro und in vivo. Strahlenther Onkol 1997;173:407-14.
50. Rübe CE, Uthe D, Schmid KW, et al. Dose dependent induction of transforming growth factor-β (TGF-β) in the lung tissue of fibrosis prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys 2000;47:1033-42.
51. Rübe CE, Uthe D, Wilfert F, et al. The bronchiolar epithelium as a prominent source of pro-inflammatory cytokines after lung irradiation. Int J Radiat Oncol Biol Phys 2004; submitted.
52. Rübe CE, vanValen F, Wilfert F, et al. Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-α (TNF-α) following radiation exposure. Int J Radiat Oncol Biol Phys 2003;56:1414-25.
53. Rübe CE, Wilfert F, Uthe D, et al. Modulation of radiation induced tumor necrosis factor-α (TNF-α) expression in the lung tissue by pentoxifylline. Radiother Oncol 2002;64:177-87.
54. Rubin P, Casarett GW. Respiratory system. In: Clinical radiation pathology, vol 1. Philadelphia: Saunders, 1968:423-70.
55. Rubin P, Johnston CJ, Williams JP, et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 1995;33:99-109.
56. Sanderson N, Factor V, Nagy P, et al. Hepatic expression of mature TGF-β1 in transgenic mice results in multiple lesions. Proc Natl Acad Sci USA 1995;92:2572-6.
57. Schultze Mosgau S, Wehrhan F, Amann K, et al. In vivo TGF-β3 expression during wound healing in irradiated tissue. An experimental study. Strahlenther Onkol 2003;179:410-6.
58. Seeland U, Haeuseter C, Hinrichs R, et al. Myocardial fibrosis in transforming growth factor-β1 (TGF-β1) transgenic mice is associated with inhibition of interstitial collagenase. Eur J Clin Invest 2002;32:295-303.
59. Sharplin J, Franko AJ. A quantitative histological study of strain dependent differences in the effects of irradiation on mouse lung during the early phase. Radiat Res 1989;119:1-14.
60. Sharplin J, Franko AJ. A quantitative histological study of strain dependent differences in the effects of irradiation on mouse lung during the intermediate and late phase. Radiat Res 1989;119:15-31.
61. Shirai Y, Kawata S, Ito N, et al. Elevated levels of plasma transforming growth factor-β in patients with hepatocellular carcinoma. Jpn J Cancer Res 1992;83:676-9.
62. Sminia P, Barten AD, van Waarde M, et al. Plasma transforming growth factor β levels in breast cancer patients. Oncol Rep 1998;5:485-8.
63. Song BC, Chung YH, Kim JA, et al. Transforming growth factor beta1 as a useful serologic marker of small hepatocellular carcinoma. Cancer 2002;94:175-80.
64. Torre Amione G, Beauchamp RD, Koeppen H, et al. A highly immunogenic tumor transfected with a murine transforming growth factor type-β1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 1990;87:1486-90.
65. Vodovotz Y, lucia MS, Delucca AM, et al. Reduced hematopoietic function and enhanced radiosensitivity of transforming growth factor-β1 transgenic mice. Int J Cancer 2000;90:13-21.
66. Vujaskovic Z, Down JD, van Waarde M, et al. Plasma TGF-β level in rats after hemithoracic irradiation. Radiother Oncol 1997;44:41-3.
67. Vujaskovic Z, Feng Q F, Rabbani ZN, et al. Radioprotection of lungs by amifostine is associated with reduction in profibrogenic cytokine activity. Radiat Res 2002;157:656-60.
68. Vujaskovic Z, Groen HJM. TGF-β radiation induced pulmonary injury and lung cancer. Int J Radiat Biol 2000;76:511-6.
69. Willner J, Jost A, Baier K, et al. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 2003;179:548-56.
70. Yi ES, Bedoya A, Lee H, et al. Radiation induced lung injury in vivo: expression of transforming growth factor-β-precedes fibrosis. Inflammation 1996;20:339-52.
71. 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res 1991;51:3590-4.